Literature DB >> 19387919

Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.

Wing-Kin Syn1, Vanessa Teaberry, Steve S Choi, Anna Mae Diehl.   

Abstract

Subpopulations of individuals with alcohol-induced fatty livers and nonalcoholic steatosis develop steatohepatitis. Steatohepatitis is defined histologically: increased numbers of injured and dying hepatocytes distinguish this condition from simple steatosis. The increased hepatocyte death is generally accompanied by hepatic accumulation of inflammatory cells and sometimes increases in myofibroblastic cells, leading to hepatic fibrosis and eventually, cirrhosis. The purpose of this review is to summarize similarities and differences in the pathogenesis of steatohepatitis in alcoholic fatty liver disease and nonalcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387919      PMCID: PMC3644873          DOI: 10.1055/s-0029-1214375

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  146 in total

1.  Gene expression in human NAFLD.

Authors:  Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

2.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

Review 3.  Signalling by CD95 and TNF receptors: not only life and death.

Authors:  C Magnusson; D L Vaux
Journal:  Immunol Cell Biol       Date:  1999-02       Impact factor: 5.126

4.  Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology.

Authors:  H Rouach; V Fataccioli; M Gentil; S W French; M Morimoto; R Nordmann
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

5.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

6.  cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha.

Authors:  J M Dong; T Leung; E Manser; L Lim
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

Review 7.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

8.  Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor.

Authors:  J R Lancaster; S M Laster; L R Gooding
Journal:  FEBS Lett       Date:  1989-05-08       Impact factor: 4.124

Review 9.  The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Michael J Pagliassotti
Journal:  J Nutr Biochem       Date:  2008-04-21       Impact factor: 6.048

10.  Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.

Authors:  Jie Zhou; Maria Febbraio; Taira Wada; Yonggong Zhai; Ramalinga Kuruba; Jinhan He; Jung Hoon Lee; Shaheen Khadem; Songrong Ren; Song Li; Roy L Silverstein; Wen Xie
Journal:  Gastroenterology       Date:  2007-11-28       Impact factor: 22.682

View more
  19 in total

Review 1.  Role of lipid rafts in liver health and disease.

Authors:  Angela Dolganiuc
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Digital analysis of hepatic sections in mice accurately quantitates triglycerides and selected properties of lipid droplets.

Authors:  Fengxia Ge; Harrison Lobdell; Shengli Zhou; Chunguang Hu; Paul D Berk
Journal:  Exp Biol Med (Maywood)       Date:  2010-10-13

3.  NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.

Authors:  Wing-Kin Syn; Kolade M Agboola; Marzena Swiderska; Gregory A Michelotti; Evaggelia Liaskou; Herbert Pang; Guanhua Xie; George Philips; Isaac S Chan; Gamze F Karaca; Thiago de Almeida Pereira; Yuping Chen; Zhiyong Mi; Paul C Kuo; Steve S Choi; Cynthia D Guy; Manal F Abdelmalek; Anna Mae Diehl
Journal:  Gut       Date:  2012-03-17       Impact factor: 23.059

4.  Kombucha tea prevents obese mice from developing hepatic steatosis and liver damage.

Authors:  Jeongeun Hyun; Youngjae Lee; Sihyung Wang; Jinnyun Kim; Jieun Kim; JaeHo Cha; Young-Su Seo; Youngmi Jung
Journal:  Food Sci Biotechnol       Date:  2016-06-30       Impact factor: 2.391

5.  Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice.

Authors:  Adrienne L King; Telisha M Swain; Zhengkuan Mao; Uduak S Udoh; Claudia R Oliva; Angela M Betancourt; Corrine E Griguer; David R Crowe; Mathieu Lesort; Shannon M Bailey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

6.  Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.

Authors:  Timea Csak; Arumugam Velayudham; Istvan Hritz; Jan Petrasek; Ivan Levin; Dora Lippai; Donna Catalano; Pranoti Mandrekar; Angela Dolganiuc; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-13       Impact factor: 4.052

7.  Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Authors:  Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

Review 8.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 9.  Obesity, diabetes mellitus, and liver fibrosis.

Authors:  Dian J Chiang; Michele T Pritchard; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

10.  Apoptosis and cytokines in non-alcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Anna Mae Diehl
Journal:  Clin Liver Dis       Date:  2009-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.